Company: SRPT
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0000950170-25-103971
Chunk: 1

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-08-06
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
SAREPTA THERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited, in thousands, except share and per share amounts)

     As of June 30, 2025

     As of December 31, 2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     510,598

     $
     1,103,010

     Short-term investments

     289,541

     251,782

     Accounts receivable, net

     527,295

     601,988

     Inventory

     994,036

     749,960

     Manufacturing-related deposits and prepaids

     207,921

     276,262

     Other current assets

     127,594

     90,461

     Total current assets

     2,656,985

     3,073,463

     Property and equipment, net

     371,857

     340,336

     Right of use assets

     143,041

     148,310

     Non-current inventory

     194,668

     187,986

     Strategic investments

     195,522

     3,710

     Non-current investments

     34,604

     133,163

     Other non-current assets

     83,137

     76,205

     Total assets
      
     $
     3,679,814

     $
     3,963,173

     Liabilities and Stockholders’ Equity

     Current liabilities:

     Accounts payable
      
     $
     136,702

     $
     214,442

     Accrued expenses

     377,399

     373,513

     Deferred revenue, current portion

     395,431

     130,256

     Other current liabilities

     10,416

     13,473

     Total current liabilities

     919,948

     731,684

     Long-term debt

     1,139,458

     1,137,124

     Lease liabilities, net of current portion

     214,419

     192,473

     Deferred revenue, net of current portion

     —

     325,000

     Contingent consideration

     47,400